Boehringer Ingelheim is categorized under Drugs, Proprietaries, and Sundries in Cosby, MO .
Boehringer Ingelheim was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Dale Buhman, Manager at the company’s single location by writing to 18030 State Route O, Cosby, Missouri MO 64436 or by phoning (816) 378-2041. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Boehringer Ingelheim |
| Contact Person: | Dale Buhman, Manager |
| Address: | 18030 State Route O, Cosby, Missouri 64436 |
| Phone Number: | (816) 378-2041 |
| Website Address: | transova.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 4242101 |
| Share This Business: |
Boehringer Ingelheim was started in 0 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Dale Buhman, Manager for inquiries that concern Boehringer Ingelheim by calling the company number (816) 378-2041, as your correspondence is most welcome. Additionally, the physical location of the single location of Boehringer Ingelheim can be found at the coordinates 39.85699,-94.70548 as well as the street address 18030 State Route O in Cosby, Missouri 64436.
For its online presence, you may visit Boehringer Ingelheim’s website at transova.com and engage with its social media outlets through on Twitter and on Facebook.